| SU 16f |
化合物 T16947 |
251356-45-3 |
| BML-259 |
BML-259 |
267654-00-2 |
| 9-OXO-11ALPHA,16R-DIHYDROXY-17-CYCLOBUTYL-5Z,13E-DIEN-1-OIC ACID |
9-OXO-11ALPHA,16R-DIHYDROXY-17-CYCLOBUTYL-5Z,13E-DIEN-1-OIC ACID |
212310-16-2 |
| AC-YVAD-AFC |
AC-TYR-VAL-ALA-ASP-AFC |
219137-85-6 |
| 2-(4-CHLOROPHENYL)-4-(4-FLUOROPHENYL)-5-PYRIDIN-4-YL-1,2-DIHYDROPYRAZOL-3-ONE |
2-(4-CHLOROPHENYL)-4-(4-FLUOROPHENYL)-5-PYRIDIN-4-YL-1,2-DIHYDROPYRAZOL-3-ONE |
219138-24-6 |
| AC-IEPD-AMC |
AC-ILE-GLU-PRO-ASP-AMC |
216757-33-4 |
| GLN-ARG-PRO-ARG-LEU-SER-HIS-LYS-GLY-PRO-MET-PRO-PHE |
人牛APELIN-13 |
217082-58-1 |
| CYCLO(-ARG-GLY-ASP-D-TYR-LYS) |
CYCLO (RGDYK) |
217099-14-4 |
| Z-VDVAD-FMK |
Z-VAL-ASP(OME)-VAL-ALA-DL-ASP(OME)-FLUOROMETHYLKETONE |
210344-92-6 |
| AC-VDVAD-AFC |
AC-VAL-ASP-VAL-ALA-ASP-AFC |
210344-94-8 |
| BAM15 |
CS-2890 |
210302-17-3 |
| CASPASE-8 INHIBITOR II |
CASPASE-8抑制剂 |
210344-98-2 |
| hVEGF-IN-1 |
1637443-98-1 |
1637443-98-1 |
| RCS-4 M9 metabolite |
RCS-4 M9 metabolite |
1630022-96-6 |
| XLR11 6-hydroxyindole metabolite |
XLR11 6-hydroxyindole metabolite |
1630022-98-8 |
| VLX600 |
VLX600 |
1622945-04-3 |
| DSP-2 |
DSP-2 |
1609395-31-4 |
| DSP-1 |
DSP-1 |
1609395-29-0 |
| UR-144 Degradant |
UR-144 Degradant |
1609273-88-2 |
| 25I-NBF (hydrochloride) |
25I-NBF (hydrochloride) |
1539266-13-1 |
